Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives.

ABSTRACT: The concept of gene therapy was introduced in the 1970s after the development of recombinant DNA technology. Despite the initial great expectations, this field experienced early setbacks. Recent years have seen a revival of clinical programs of gene therapy in different fields of medicine. There are many promising targets for genetic therapy as an adjunct to cardiac surgery. The first positive long-term results were published for adenoviral administration of vascular endothelial growth factor with coronary artery bypass grafting. In this review we analyze the past, present, and future of gene therapy in cardiac surgery. The articles discussed were collected through PubMed and from author experience. The clinical trials referenced were found through the Wiley clinical trial database (http:/

SUBMITTER: Katz MG 

PROVIDER: S-EPMC4987708 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature